Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic steatohepatitis (NASH) is defined as a progressive form of nonalcoholic fatty liver disease (NAFLD) and is a common chronic liver disease that causes significant worldwide morbidity and mortality, and has no approved pharmacotherapy. Nevertheless, growing understanding of the molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyeongjin, Kim, Kook Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177791/
https://www.ncbi.nlm.nih.gov/pubmed/32225108
http://dx.doi.org/10.3390/ijms21072296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177791/
https://www.ncbi.nlm.nih.gov/pubmed/32225108
http://dx.doi.org/10.3390/ijms21072296

Ejemplares similares